We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+11.15%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$1.23B
AUM Growth
-$126M
Cap. Flow
-$64.2M
Cap. Flow %
-5.23%
Top 10 Hldgs %
47.46%
Holding
461
New
283
Increased
16
Reduced
28
Closed
90

Sector Composition

Rank Sector Weight
1 Healthcare 24.64%
2 Financials 19.07%
3 Materials 14.06%
4 Technology 13.25%
5 Consumer Discretionary 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QS icon
326
QuantumScape Corp
QS
$3.22B
$184K 0.02%
+17,665
New +$244K
INTR icon
327
Inter&Co
INTR
$2.49B
$182K 0.01%
+21,482
New +$190K
GROY icon
328
Gold Royalty Corp
GROY
$621M
$181K 0.01%
+44,769
New +$171K
IHS icon
329
IHS Holding
IHS
$2.76B
$181K 0.01%
+24,214
New +$167K
FTK icon
330
Flotek Industries
FTK
$847M
$177K 0.01%
+10,275
New +$163K
TDUP icon
331
ThredUp
TDUP
$757M
$176K 0.01%
+27,473
New +$222K
HLF icon
332
Herbalife
HLF
$1.29B
$175K 0.01%
+13,567
New +$144K
ASIX icon
333
AdvanSix
ASIX
$555M
$174K 0.01%
+10,038
New +$175K
OOMA icon
334
Ooma
OOMA
$589M
$172K 0.01%
+14,704
New +$168K
ILPT
335
Industrial Logistics Properties Trust
ILPT
$565M
$166K 0.01%
+29,912
New +$165K
SB icon
336
Safe Bulkers
SB
$810M
$166K 0.01%
+34,377
New +$163K
VGZ icon
337
Vista Gold
VGZ
$260M
$165K 0.01%
+83,760
New +$162K
DMAAR
338
Drugs Made In America Acquisition Corp Rights
DMAAR
$159K 0.01%
850,000
WULF icon
339
TeraWulf
WULF
$8.83B
$152K 0.01%
+13,191
New +$177K
REI icon
340
Ring Energy
REI
$315M
$145K 0.01%
+166,595
New +$159K
NB
341
NioCorp Developments
NB
$626M
$135K 0.01%
+25,540
New +$176K
DDL
342
Dingdong
DDL
$529M
$132K 0.01%
+53,141
New +$106K
RLMD icon
343
Relmada Therapeutics
RLMD
$562M
$132K 0.01%
+27,380
New +$91.7K
XNET
344
Xunlei
XNET
$360M
$128K 0.01%
+18,025
New +$145K
EGY icon
345
Vaalco Energy
EGY
$567M
$127K 0.01%
+34,815
New +$129K
AIIA.RT
346
AI Infrastructure Acquisition Corp Rights
AIIA.RT
$117K 0.01%
+450,000
New +$120K
TSHA icon
347
Taysha Gene Therapies
TSHA
$1.69B
$113K 0.01%
+20,546
New +$99.8K
CTMX icon
348
CytomX Therapeutics
CTMX
$714M
$112K 0.01%
+26,265
New +$99.8K
TOI icon
349
The Oncology Institute
TOI
$507M
$109K 0.01%
+30,581
New +$113K
IVVD icon
350
Invivyd
IVVD
$171M
$104K 0.01%
+42,127
New +$87.6K

Similar funds

Mangrove Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Mangrove Partners held 461 positions worth $1.23B, down 9.3% from $1.35B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Mangrove Partners withdrew a net $64.2M in Q4 2025, closing 90 positions and reducing 28 holdings. Its most notable exit was Somnigroup International, an estimated $48.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 20% a quarter earlier, followed by Financials and Materials.

Against the trend, Mangrove Partners opened a new position in Becton Dickinson worth $48M.

  • Mangrove Partners's largest Q4 2025 buy was Becton Dickinson: 247,317 shares worth $48M.
  • Mangrove Partners added most to REX American Resources in Q4 2025, an estimated $15.9M increase.
  • Mangrove Partners's biggest Q4 2025 reduction was Enova International, cutting an estimated $27.4M.
  • Mangrove Partners fully exited Somnigroup International in Q4 2025, selling an estimated $48.6M.
  • Mangrove Partners's ten largest holdings make up 47% of its $1.23B portfolio in Q4 2025.
  • Mangrove Partners opened 283 new positions and closed 90 in Q4 2025.
  • Mangrove Partners's portfolio value fell 9.3% quarter-over-quarter to $1.23B.

Based on Mangrove Partners's 13F filing for Q4 2025, filed 17 Feb 2026.